Satellos Bioscience Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-15
Interim MD&A - English.pdf
Results 2026-05-15
Interim financial statements/report – English.pdf
Results 2026-05-15
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress
News release - English.pdf
Ownership 2026-04-07
Nawacki, Mark Henry · 10 - Acquisition or disposition in the public market
Insider trading – 2026-04-07
1 insider · $0 net
Results 2026-03-27 Financials
Annual information form - English.pdf
Results 2026-03-27 Financials
Annual MD&A - English.pdf
Results 2026-03-27 Financials
Audited annual financial statements – English.pdf
Results 2026-03-27
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
News release - English.pdf
Ownership 2026-03-13
Nawacki, Mark Henry · 10 - Acquisition or disposition in the public market
Insider trading – 2026-03-13
1 insider · $0 net
Results 2026-03-10
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
News release - English.pdf
News 2026-02-24
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
News release - English.pdf
News 2026-02-18
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
News release - English.pdf
Transactions 2026-02-13 Financing
Satellos Bioscience Inc. Announces Pricing of Public Offering and Nasdaq Listing
Material change report - English.pdf
Ownership 2026-02-13
BERGER, FRANKLIN MILAN bought +$250k
Insider trading – 2026-02-13
1 insider · +$250k net
News 2026-02-12
Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
News release - English.pdf
News 2026-02-10
Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
News release - English.pdf
Transactions 2026-02-09 Financing
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters' Option to Purchase Additional Shares
News release - English.pdf
News 2026-02-06
Underwriting or agency agreements (or amendment thereto).pdf
Transactions 2026-02-06
Prospectus (non pricing) supplement (other than ATM) – English.pdf
News 2026-02-06
Consent letter of underwriters' legal counsel.pdf
News 2026-02-06
Consent letter of issuer's legal counsel.pdf
Transactions 2026-02-06 Financing
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
News release - English.pdf
Transactions 2026-02-05 Financing
Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq
News release - English.pdf
Transactions 2026-02-05
Draft shelf prospectus supplement – English.pdf
Transactions 2026-01-30 M&A
Satellos Bioscience Inc. Completes Share Consolidation and Announces Appointment of Chief Development Officer
Material change report - English.pdf
News 2026-01-30
Certificate and Articles of Amendment.pdf
News 2025-12-09
Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy
News release - English.pdf
News 2025-11-18
Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy
News release - English.pdf
Results 2025-11-14 Financials
Interim financial statements/report – English.pdf
Results 2025-11-14 Financials
Interim MD&A - English.pdf
News 2025-11-14
News release - English.pdf
News 2025-10-30
Notice to the Public.pdf
News 2025-10-30
Decision Document (Final).pdf
News 2025-10-30
News release - English.pdf
Transactions 2025-10-29 Financing
Final short form prospectus – English.pdf
Transactions 2025-10-29 Financing
Undertaking to file documents and material contracts.pdf
News 2025-10-21
News release - English.pdf
News 2025-10-10
News release - English.pdf
News 2025-09-29
Decision Document (Preliminary).pdf
News 2025-09-29
News release - English.pdf
Transactions 2025-09-26 Financing
Preliminary short form prospectus – English.pdf
News 2025-09-22
News release - English.pdf
News 2025-08-21
News release - English.pdf
News 2025-08-13
News release - English.pdf
Results 2025-08-13 Financials
Interim MD&A - English.pdf
Results 2025-08-13 Financials
Interim financial statements/report – English.pdf
News 2025-08-05
News release - English.pdf
News 2025-07-16
News release - English.pdf
News 2025-06-18
News release - English.pdf
News 2025-06-18
News release - English.pdf
News 2025-06-16
News release - English.pdf
Ownership 2025-03-04
Gleeson, Francis (Frank) Michael bought +$244k
Insider trading – 2025-03-04
1 insider · +$244k net
Ownership 2025-02-21
McVicar, William Kenneth bought +$19k
Insider trading – 2025-02-21
1 insider · +$19k net
Ownership 2025-02-11
Jarosz, William Wasyl bought +$30k
Insider trading – 2025-02-11
1 insider · +$30k net
Ownership 2024-12-20
4 insiders · +$4.9M net
Insider trading – 2024-12-20
4 insiders · +$4.9M net
Ownership 2024-10-31
Bloom, Brian Matthew bought +$48k
Insider trading – 2024-10-31
1 insider · +$48k net
Ownership 2024-10-25
Rudnicki, Michael Anthony bought +$10k
Insider trading – 2024-10-25
1 insider · +$10k net
Ownership 2024-10-09
BERGER, FRANKLIN MILAN bought +$428k
Insider trading – 2024-10-09
1 insider · +$428k net
Ownership 2024-10-02
Cross, Michael Collins bought +$2k
Insider trading – 2024-10-02
1 insider · +$2k net